Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders

Frontiers in Neuroscience - Switzerland
doi 10.3389/fnins.2016.00408
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Frontiers Media SA

Related search

Axon Pathology in Parkinson's Disease and Lewy Body Dementia Hippocampus Contains Alpha -, Beta -, and Gamma -Synuclein

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Erratum: Multisystem Lewy Body Disease and the Other Parkinsonian Disorders

Nature Genetics
Genetics
2016English

Alpha-Synuclein Repeat Variants and Survival in Parkinson's Disease

Movement Disorders
Neurology
2014English

Temperature-Dependent Structural Changes of Parkinson's Alpha-Synuclein Reveal the Role of Pre-Existing Oligomers in Alpha-Synuclein Fibrillization

PLoS ONE
Multidisciplinary
2013English

Alpha-Synuclein Mutations Impair Axonal Regeneration in Models of Parkinson's Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2014English

Inflammation in Mild Cognitive Impairment Due to Parkinson's Disease, Lewy Body Disease and Alzheimer's Disease

International Journal of Geriatric Psychiatry
PsychiatryGerontologyGeriatricsMental Health
2019English

Divulging Characteristic Features of the Novel A-Synuclein Oligomers Augmenting Parkinson's Disease

Biophysical Journal
Biophysics
2019English

Deubiquitinase Usp8 Regulates Α-Synuclein Clearance and Modifies Its Toxicity in Lewy Body Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2016English

A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease

Frontiers in Neurology
Neurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy